5 Key Takeaways

• 1

  Mass spectrometry imaging (MSI) has struggled to gain adoption in clinical diagnostics despite its analytical power and potential.

• 2

  Traditional MSI relies on fresh-frozen samples, while most pathology labs use formalin-fixed paraffin-embedded (FFPE) tissues.

• 3

  Recent research shows high-resolution mass spectrometry histochemistry (MSHC) can effectively analyze archived FFPE tissues.

• 4

  MSHC can enhance diagnostic accuracy and integrate into existing lab workflows without altering specimen processing.

• 5

  The implementation of MSHC could revolutionize disease classification and treatment personalization in pathology.